Fighting Cancer with Vaccinia Virus: Teaching New Tricks to an Old Dog
Open Access
- 1 February 2005
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 11 (2) , 180-195
- https://doi.org/10.1016/j.ymthe.2004.10.015
Abstract
No abstract availableKeywords
This publication has 176 references indexed in Scilit:
- Immunization of Patients with Malignant Melanoma with Autologous CD34+Cell-Derived Dendritic Cells TransducedEx Vivowith a Recombinant Replication-Deficient Vaccinia Vector Encoding the Human Tyrosinase Gene: A Phase I TrialHuman Gene Therapy, 2003
- Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genesCancer Gene Therapy, 2002
- Development of a replication-selective, oncolytic poxvirus for the treatment of human cancersCancer Gene Therapy, 2002
- Assembly of vaccinia virus revisited: de novo membrane synthesis or acquisition from the host?Trends in Microbiology, 2002
- Complex interactions between the replicating oncolytic effect and the enzyme/prodrug effect of vaccinia-mediated tumor regressionGene Therapy, 2000
- Structure of vaccinia virus late promotersJournal of Molecular Biology, 1989
- Structure of vaccinia virus early promotersJournal of Molecular Biology, 1989
- Infectious poxvirus vectors have capacity for at least 25 000 base pairs of foreign DNAGene, 1983
- The replication and coating of vaccinia DNAJournal of Molecular Biology, 1964
- THE DEVELOPMENT OF VACCINIA VIRUS IN EARLE'S L STRAIN CELLS AS EXAMINED BY ELECTRON MICROSCOPYThe Journal of cell biology, 1961